EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expression Analysis of Circulating miR-21, miR-34a and miR-122 and Redox Status Markers in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients with and Without Type 2 Diabetes

Sanja Erceg iD, Jelena Munjas iD, Miron Sopić, Ratko Tomašević, Miloš Mitrović iD, Jelena Kotur-Stevuljević, Milica Mamić, Sanja Vujčić, Aleksandra Klisic iD, Ana Ninić iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26062392 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sanja Erceg und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, 11221 Belgrade, Serbia. Hauptthemen laut MEDLINE: MicroRNAs, Diabetes Mellitus, Type 2, Fatty Liver, Metabolic Syndrome. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development and Innovation, Republic of Serbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD), a hepatic form of metabolic syndrome, often co-occurs with type 2 diabetes (T2D) and now affects approximately 30% of the global population. MASLD encompasses conditions from simple steatosis to metabolic dysfunction-associated steatohepatitis, with oxidative stress (OS) driving progression through inflammation. This study analyzes the expression levels of circulating miRNAs and redox status markers in MASLD patients with and without T2D, exploring their potential as disease biomarkers. The expressions of miR-21, miR-34a, and miR-122 were analyzed in the platelet-poor plasma of 147 participants, divided into three groups: MASLD + T2D (48), MASLD (50), and a control group (49). Total oxidant status (TOS), total antioxidant status (TAS), ischemia-modified albumin (IMA), and superoxide anion radical (O2•−) were measured in serum and plasma. Logistic regression showed that miR-21, miR-34a, TOS, TAS, O2•−, and IMA were positive predictors of MASLD, while miR-21 and TAS were negative predictors of T2D in MASLD. Although miR-122 did not show a significant association with either condition, in combination with miR-34a and other markers such as lipid status and liver enzymes, a new significant predictor of MASLD was identified. Circulating miRNAs in combination with redox status markers, lipid status and liver enzymes show potential as MASLD biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsDiabetes Mellitus, Type 2Fatty LiverMetabolic SyndromeHumansMaleFemaleMiddle AgedBiomarkersOxidation-ReductionOxidative StressAgedAdult

Stichwörter der Autor:innen

MASLDcirculating miRNAoxidative stressredox statustype 2 diabetes

Substanzen

MicroRNAsMIRN122 microRNA, humanBiomarkersMIRN21 microRNA, humanMIRN34 microRNA, human

Autor:innen und Institutionen

  • Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, 11221 Belgrade, Serbia.
  • Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
  • Department of Gastroenterology and Hepatology, Clinic for Internal Medicine, Clinical Hospital Center Zemun, 11080 Belgrade, Serbia.
  • Clinical Department for Gastroenterology and Hepatology, University Medical Center Zvezdara, 11120 Belgrade, Serbia.
  • Department of Laboratory Diagnostics, Clinical Hospital Center Zemun, 11080 Belgrade, Serbia.
  • Faculty of Medicine, University of Montenegro, 81000 Podgorica, Montenegro.

ORCID-Profile: Sanja Erceg, Jelena Munjas, Miloš Mitrović, Aleksandra Klisic, Ana Ninić

Förderung

  • Ministry of Science, Technological Development and Innovation, Republic of Serbia

Zitieren

APA

Erceg, S., Munjas, J., Sopić, M., Tomašević, R., Mitrović, M., Kotur-Stevuljević, J., Mamić, M., Vujčić, S., Klisic, A., & Ninić, A. (2025). Expression Analysis of Circulating miR-21, miR-34a and miR-122 and Redox Status Markers in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients with and Without Type 2 Diabetes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26062392

Vancouver

Erceg S, Munjas J, Sopić M, Tomašević R, Mitrović M, Kotur-Stevuljević J, et al. Expression Analysis of Circulating miR-21, miR-34a and miR-122 and Redox Status Markers in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients with and Without Type 2 Diabetes. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26062392

BibTeX
@article{Erceg2025,
  author = {Erceg, Sanja and Munjas, Jelena and Sopić, Miron and Tomašević, Ratko and Mitrović, Miloš and Kotur-Stevuljević, Jelena and Mamić, Milica and Vujčić, Sanja and Klisic, Aleksandra and Ninić, Ana},
  title = {Expression Analysis of Circulating miR-21, miR-34a and miR-122 and Redox Status Markers in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients with and Without Type 2 Diabetes},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26062392}
}
Kostenlos starten →